This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2lms
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | [[Image:2lms.jpg|left|200px]] | ||
| - | |||
{{STRUCTURE_2lms| PDB=2lms | SCENE= }} | {{STRUCTURE_2lms| PDB=2lms | SCENE= }} | ||
| - | |||
===A single GalNAc residue on Threonine-106 modifies the dynamics and the structure of Interferon alpha-2a around the glycosylation site=== | ===A single GalNAc residue on Threonine-106 modifies the dynamics and the structure of Interferon alpha-2a around the glycosylation site=== | ||
| + | {{ABSTRACT_PUBMED_23184955}} | ||
| + | ==Function== | ||
| + | [[http://www.uniprot.org/uniprot/IFNA2_HUMAN IFNA2_HUMAN]] Produced by macrophages, IFN-alpha have antiviral activities. | ||
==About this Structure== | ==About this Structure== | ||
Revision as of 06:45, 2 May 2013
A single GalNAc residue on Threonine-106 modifies the dynamics and the structure of Interferon alpha-2a around the glycosylation site
Template:ABSTRACT PUBMED 23184955
Function
[IFNA2_HUMAN] Produced by macrophages, IFN-alpha have antiviral activities.
About this Structure
2lms is a 1 chain structure with sequence from Homo sapiens. Full experimental information is available from OCA.
